Form 4 for SILO Silo Pharma, Inc.
Accepted 2025-11-21 00:00:00 ET · period of report 2025-11-20 · accession 0001213900-25-113743 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-21 | 2025-11-20+ | SILO | Weisblum Eric | CEO, Dir | P - Purchase | $0.37 | +2,000 | 211.9K | +1.0% | +$740 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-20 | P | A | 1,000 | $0.37 | 210,932 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-21 | P | A | 1,000 | $0.37 | 211,932 | D | — | — |